Adrienne Farid - Jun 17, 2021 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Chief Operations Officer
Signature: By: /s/ Michael Diem, Attorney-in-Fact
Stock symbol: IPSC
Transactions as of: Jun 17, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/17/2021, 05:02 PM
Next filing: Jan 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IPSC	Common Stock						74.2K	Jun 17, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IPSC	Stock Option (right to buy)							Jun 17, 2021	Common Stock	223K	$1.03	Direct	F1
holding	IPSC	Stock Option (right to buy)							Jun 17, 2021	Common Stock	208K	$7.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests 25% on March 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.
F2	The option vests 25% on the first anniversary of the closing of the Issuer's initial public offering, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.